drug shortages

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

Market Access

Navigating new risks: How China’s Anti-Espionage Law could i...

The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential

Patients

Managing the UK's ADHD medication supply crisis with accessi...

Recent statistics from the NHS have highlighted an increase in prescribed medicine for attention deficit hyperactivity disorder (ADHD) over the past year,

News

Mounjaro and Zepbound shortages over, declares FDA

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in

Digital

Innovating pharma: How technology can ensure a steady medica...

The pharmaceutical industry faces an urgent challenge: frequent drug shortages that threaten patient care and public health.

R&D

The end of drug shortages begins with data transparency

For more than 15 years, shortages of critical drugs — from oncology treatments to emergency room and surgical suite essentials — have burdened healthcare systems and compromised patient car